Increased expression of phosphorrylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndrome... by Kefala, M, Papageorgiou, S, Kontos, C, Economopoulou, P, Tsanas, A, Panayiotides, I, Gorgoulis, V, Patsouris, E, Foukas, P

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits by Sinapis C, Routsias JG, Sinapis A, Sinapis D, Agrogiannis G, Pantopoulou A, Theocharis SE, Baltatzis S, Patsouris E, Perrea DN

Get full text

Assessment of α-Synuclein Pathology by Alafuzoff, I, Parkkinen, L, Al-Sarraj, S, Arzberger, T, Bell, J, Bodi, I, Bogdanovic, N, Budka, H, Ferrer, I, Gelpi, E, Gentleman, S, Giaccone, G, Kamphorst, W, King, A, Korkolopoulou, P, Kovács, G, Larionov, S, Meyronet, D, Monoranu, C, Morris, J, Parchi, P, Patsouris, E, Roggendorf, W, Seilhean, D, Streichenberger, N, Thal, D, Kretzschmar, H

Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium by Alafuzoff, I, Ince, P, Arzberger, T, Al-Sarraj, S, Bell, J, Bodi, I, Bogdanovic, N, Bugiani, O, Ferrer, I, Gelpi, E, Gentleman, S, Giaccone, G, Ironside, J, Kavantzas, N, King, A, Korkolopoulou, P, Kovács, G, Meyronet, D, Monoranu, C, Parchi, P, Parkkinen, L, Patsouris, E, Roggendorf, L, Rozemuller, A, Stadelmann-Nessler, C, Streichenberger, N, Thal, D, Kretzschmar, H